Total Funding
12
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
469768
Clarient provides oncology testing and diagnostic services in the United States.
Acquired by 
NeoGenomics
- Irwin Scher: DirectorPast Role: Merck, Business Consultant to the Chief Executive Officer
About the Company
Clarient is a leading provider of cancer diagnostic testing. They work with local pathologists and oncologists to bring the standard of care back into their community. They're dedicated to providing clarity to complex problems by using a number of technologies to help their clients diagnose cancer cases. They also provide them insight into
what therapies will work best for these patients, and continue with follow-up and case monitoring.
